• BIO 381 Pathophysiology
  • WEEK 1. INNATE IMMUNITY AND INFLAMMATION
  • WEEK 2. ADAPTIVE IMMUNITY, LEUKEMIA, AND OTHER BLOOD CELL PATHOLOGIES
  • WEEK 3. HEMOSTASIS AND RED BLOOD CELLS
  • WEEK 4. CARDIOVASCULAR SYSTEM
  • WEEK 5. ENDOCRINE DISORDERS
  • WEEK 6. NEUROLOGICAL DISORDERS
  • WEEK 7. MIDTERM EXAM
  • WEEK 8. DISORDERS OF GI FUNCTION
  • WEEK 9. RESPIRATORY DISORDERS
  • WEEK 10. SKELETAL, VISION, AND HEARING DISORDERS
  • WEEK 11. PAIN, HEADACHE, AND REPRODUCTIVE SYSTEM DISORDERS
  • WEEK 12. RENAL DISORDERS
  • Download
  • Translations
  • WEEK 3

    HEMOSTASIS AND RED BLOOD CELLS

    Objectives:

    1. Be able to explain the platelet plug, clotting factors and coagulation cascade.
    2. Explain the mechanisms that work to prevent platelet activation and blood clotting.
    3. Describe how blood clots are broken down and dissolved.
    4. Explain the disorders of hemostasis mentioned in the study guide.
    5. Explain how red blood cells are produced and broken down.
    6. Describe these red blood cell disorders: spherocytosis, sickle cell, thalassemia, iron deficiency, megaloblastic anemia and polycythemia.

    Vocabulary:

    • Activated partial thromboplastin time (aPTT)
    • ADPase
    • Antithrombin (AT-III)
    • Biliverdin
    • Disseminated intravascular coagulation (DIC)
    • Ecchymoses
    • Ferritin
    • Ferroportin 1
    • Fibrinogen
    • GPIIb/IIIa receptor
    • Helmet cells (schistocytes)
    • Hemoglobin breakdown
    • Hemolytic-uremic syndrome (HUS)
    • Hemophilia A&B
    • Hemostasis

    • Heparin (UFH and LMWH)
    • Heparin-induced thrombocytopenia and thrombosis (HIT/HITT)
    • Hepcidin
    • Hephaestin
    • Immune thrombocytopenic purpura (ITP)
    • International normalized ratio (INR)
    • Mean corpuscular volume (MCV)
    • Mean corpuscular hemoglobin concentration (MCHC)
    • Nitric oxide (NO)
    • Pernicious anemia
    • Petechiae
    • Plasminogen/plasmin

    • Platelet activating factor (PAF)
    • Polycythemia
    • Prothrombin time (PT)
    • Prostacyclin
    • Purpura
    • Thalassemia
    • Thrombin
    • Thrombocyte
    • Thrombocytopenia
    • Thrombotic thrombocytopenic purpura (TTP)
    • Thrombomodulin
    • Thromboxane (TXA2)
    • Tissue factor pathway inhibitor (TFPI)
    • Tissue plasminogen activator (tPA)
    • Transferrin
    • vWF
    • Warfarin (Coumadin)

    HemostasisHealthy Endothelium – Endogenous Antiplatelets and AnticoagulantsThe Stages of HemostasisInherited (Primary) Disorders NOT Involving PlateletsInherited (Primary) Disorders Involving PlateletsAcquired (Secondary) Disorders NOT Directly Involving PlateletsAcquired (Secondary) Disorders Directly Involving PlateletsRed Blood CellsHemoglobin and the Breakdown of HemoglobinImportant Red Blood Cell Lab TestsDisorders of the Red Blood Cell Membrane Types of ThalassemiaRole of Iron and Iron Deficiency AnemiaMegaloblastic AnemiasAplastic and Chronic Disease AnemiaPolycythemia

    This content is provided to you freely by BYU-I Books.

    Access it online or download it at https://books.byui.edu/bio_381_pathophysiol/week_3_hemostasis_an.